Cardiovascular pharmacogenomics and individualized drug therapy

被引：51
|
作者：
Pereira, Naveen L. [1 ]
Weinshilboum, Richard M. [2 ]
机构：
[1] Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Clin Pharmacol, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
来源：
NATURE REVIEWS CARDIOLOGY | 2009年 / 6卷 / 10期
关键词：
CONGESTIVE-HEART-FAILURE; CYP2D LOCUS; WARFARIN; POLYMORPHISMS; ASSOCIATION; METABOLISM; GENE; IDENTIFICATION; DEBRISOQUINE; INFORMATION;
D O I：
10.1038/nrcardio.2009.154
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The goal of individualized drug therapy requires physicians to be able to accurately predict an individual's response to a drug. Both genetic and environmental factors are known to influence drug response. 'Pharmacogenetics' is the study of the role of inheritance in variation in drug response phenotypes. Pharmacogenetics is now moving genome-wide to become 'pharmacogenomics', resulting in the recognition of novel biomarkers for individual variation in drug response. This article reviews the development, promise and challenges facing pharmacogenomics, using examples of drugs used to treat or prevent cardiovascular disease.
引用
收藏
页码：632 / 638
页数：7
相关论文
共 50 条
  • [41] Cardiovascular pharmacogenomics
    Johnson, JA
    Cavallari, LH
    [J]. EXPERIMENTAL PHYSIOLOGY, 2005, 90 (03) : 283 - 289
  • [42] Cardiovascular Pharmacogenomics
    Roden, Dan M.
    Johnson, Julie A.
    Kimmel, Stephen E.
    Krauss, Ronald M.
    Medina, Marisa Wong
    Shuldiner, Alan
    Wilke, Russell A.
    [J]. CIRCULATION RESEARCH, 2011, 109 (07) : 807 - 820
  • [43] Cardiovascular pharmacogenomics
    Roden, DM
    [J]. CIRCULATION, 2003, 108 (25) : 3071 - 3074
  • [44] Moving towards individualized medicine with pharmacogenomics
    Evans, WE
    Relling, MV
    [J]. NATURE, 2004, 429 (6990) : 464 - 468
  • [45] Pharmacogenetics and pharmacogenomics: Pathways to individualized treatment?
    Claes, SJ
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S134 - S134
  • [46] Status of pharmacogenomics and its future role in drug therapy
    Cascorbi, I
    [J]. INTERNIST, 2002, 43 (04): : 506 - 510
  • [47] Pharmacogenomics: The Key to Improved Drug Therapy in Transplant Patients
    Burckart, Gilbert J.
    [J]. CLINICS IN LABORATORY MEDICINE, 2008, 28 (03) : 411 - +
  • [48] Pharmacogenomics: Unlocking the human genome for better drug therapy
    McLeod, HL
    Evans, WE
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 : 101 - 121
  • [49] Drug Therapy and Personalized Health Care: Pharmacogenomics in Perspective
    Sadee, Wolfgang
    [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (12) : 2713 - 2719
  • [50] Drug Therapy and Personalized Health Care: Pharmacogenomics in Perspective
    Wolfgang Sadee
    [J]. Pharmaceutical Research, 2008, 25 : 2713 - 2719
12345